Daniel Blumenthal is an accomplished professional in the biotechnology and preclinical development sectors, currently serving as the Director of Preclinical Programs at Immunai since September 2025. Previously, Daniel held various leadership positions at Carisma Therapeutics, where responsibilities included directing preclinical programs for innovative therapies and overseeing the development of CAR-Monocyte products aimed at solid tumors and liver fibrosis. Additionally, Daniel contributed to the academic community as a postdoctoral researcher at the Children's Hospital of Philadelphia, focusing on dendritic cell mechanics, and served as a lecturer and teaching assistant at multiple educational institutions. Daniel earned a PhD in Biotechnology Engineering from Ben-Gurion University of the Negev, after completing both a master's and a bachelor's degree in the same field.
This person is not in the org chart
This person is not in any teams
This person is not in any offices